ALT
NASDAQ · Biotechnology
Altimmune Inc
$2.97
+0.04 (+1.37%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+255.2% upside
Low Target
$6.68
Average Target
$10.55
High Target
$11.58
Current Price
$2.97
Current
$2.97
$2.97
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Scenario Analysis
Bear Case
$6.68
124.9%
Low target
Base Case
$10.55
+255.2%
Avg target
Bull Case
$11.58
+289.9%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.73
-61.6% from high
52-Week Low
$2.56
+16.0% from low
Target vs 52W High
$10.55
+36.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |